Clinical Trial Update: Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid

View source ↗

Summary

A completed clinical trial assessing the effect of different dosages of Anti-PB230, Anti-PB180 and cytokines for monitoring Bullous Pemphigoid.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bullous Pemphigoid

Drugs mentioned

• Anti-PB180
• Anti-PB230
• Cytokines

Snippet

Sponsor: CHU de Reims | Conditions: Bullous Pemphigoid | Status: COMPLETED